Drug Shortage Report for ACT ETIDROCAL

Last updated on 2019-02-21 History
Report ID 57207
Drug Identification Number 02263866
Brand name ACT ETIDROCAL
Common or Proper name ETIDROCAL
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) ETIDRONATE DISODIUM CALCIUM
Strength(s) 400MG 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-02-21
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2019-02-21 French Compare
v15 2019-02-21 English Compare
v14 2019-02-21 English Compare
v13 2019-01-31 French Compare
v12 2019-01-31 English Compare
v11 2019-01-03 French Compare
v10 2019-01-03 English Compare
v9 2018-12-04 French Compare
v8 2018-12-04 English Compare
v7 2018-11-20 French Compare
v6 2018-11-20 English Compare
v5 2018-11-20 English Compare
v4 2018-10-11 French Compare
v3 2018-10-11 English Compare
v2 2018-08-01 French Compare
v1 2018-08-01 English Compare